πŸ‡ΊπŸ‡Έ FDA
Patent

US 8227615

Pyridyl derivatives as CFTR modulators

granted A61PA61P11/00A61P11/02

Quick answer

US patent 8227615 (Pyridyl derivatives as CFTR modulators) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61P, A61P11/00, A61P11/02, A61P13/02, A61P13/12